『Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity』のカバーアート

Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity

Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

In this episode of the Medical News Update, we discuss the FDA's approval of Zepbound (tirzepatide), a groundbreaking drug for treating moderate to severe obstructive sleep apnea in adults with obesity. Learn about the condition, how the medication works, clinical trial results, and potential risks and limitations. Stay informed about the latest medical advancements with our updates.

00:00 Introduction to Medical News Update

00:03 FDA Approves Zepbound for Obstructive Sleep Apnea

00:27 Understanding Obstructive Sleep Apnea

00:43 How Zepbound Works

00:58 Clinical Trials and Results

01:35 Considerations and Risks

02:06 Conclusion and Final Thoughts

02:22 Subscribe for More Medical Insights

Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesityに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。